JN1017C - mCRPC - UK
Research type
Research Study
Full title
Qualitative Study to Understand the Emotional Response to a Metastatic Diagnosis in Castration-Resistant Prostate Cancer (CRPC)
IRAS ID
222220
Contact name
Jason Randall
Contact email
Sponsor organisation
Clinical Outcomes Solutions
Clinicaltrials.gov Identifier
JN1017C , Emotional impact of mCRPC
Duration of Study in the UK
0 years, 1 months, 30 days
Research summary
The overall aim of this project is to assess the emotional response of men with Castration-Resistant Prostate Cancer (CRPC), post-metastatic diagnosis. This research is being undertaken to understand the emotional burden of metastatic Castration-Resistant Prostate Cancer (mCRPC) on patients to support the development of a new drug.
This study will involve in-depth, qualitative, one-to-one telephone Interviews with men (n = 8) with a recent diagnosis of metastatic Castration-Resistant Prostate Cancer (mCRPC). In addition, for a subsample of patients (n=4), interviews will also be conducted with the patient’s primary support person (a friend or family member who has provided support to the patient emotionally and/or in everyday tasks/care). Interviews will be conducted to the point of saturation (when there are no new concepts emerging from subsequent interviews), and so additional interviews may potentially be conducted until this is achieved. No intervention or treatment will be administered as part of this study.
As well as this UK study, this research is also being undertaken in the US, France and Germany, and is currently under ethical review in these countries.
REC name
East Midlands - Leicester Central Research Ethics Committee
REC reference
17/EM/0139
Date of REC Opinion
16 May 2017
REC opinion
Further Information Favourable Opinion